Pancreatic Adenocarcinoma — Trials

Pancreatic Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

914 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 356
Recruiting: 210
Ph III recruiting: 23
Growth YoY: +41.4%
Industry share: 41%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (136)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07344220	Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate(DZ-002-201)	enrolling by invitation	Phase 2	39	Hoag Memorial Hospital PresbyterianOTHER	1	Sep 23, 2026	clinicaltrials
NCT06157671	The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma	enrolling by invitation	—	1,000	Adenocyte, LLCINDUSTRY	1	Aug 6, 2026